FDA Process For COVID-19 Test
FDA has announced Emergency Use Authorization (EUA) for a 5-minute point-of-care COVID-19 test, the virus that produces the novel coronavirus, according to a press statement….
FDA
Patient Care vs. Drug Shortage Due To COVID-19
As the COVID-19 pandemic continues to extend the U.S. healthcare system and limit the number of state health care providers, APhA and other major chemistry…
Hand Sanitizers Might Save Thousands Of Lives – FDA
The first group of combined hand sanitizers has been delivered to first responders in Southeast Texas, following federal regulators’ approval for compounding pharmacies to produce…
FDA vs. New York State Department of Health: Authorization And Diagnostic
The U.S. Food and Drug Administration (FDA) received two crucial actions in the agency’s continuing and aggressive dedication to addressing the coronavirus outbreak (COVID19). Principally,…
The Coronavirus Break: The FDA News
The FDA is currently delaying most international reviews through April, active immediately, due to the global COVID-19 break, one and the company is considering actions…
FDA vs. The Group of Progressive Interstitial Lung Diseases
The U.S. Food and Drug Administration now signed Ofev (nintedanib) oral capsules to manage the sufferers with chronic fibrosing (scarring) interstitial lung diseases (ILD) with…
FDA Approves First Generic of Daraprim
The U.S. Food and Drug Administration has established an application for the first generic of Daraprim (pyrimethamine) pills for the treatment of toxoplasmosis (an infection…
FDA OKs New Non-Statin, LDL-C Lowering Treatment
Esperion bempedoic acid (Nexletol) tablet has gained FDA approval for use in lowering low-density lipoprotein cholesterol (LDL-C) in adults with heterozygous familial hypercholesterolemia (HeFH) or…
FDA Endorses First Generic Of ProAir HFA
The U.S. Food and Drug Administration (FDA) has accepted the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the therapy or blocking of…
FDA vs. Smooth Regulatory Transition of Insulin
Now, the U.S. Food and Drug Administration took extra steps to secure a smooth regulatory change aimed at improving patient access to insulin results used…